[Peracute meningococcal infection (Waterhouse Friderichsen syndrome)].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D003879:Dermatologic Agents; D006801:Humans; D008589:Meningococcal Infections; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D014884:Waterhouse-Friderichsen Syndrome
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D003348:Cortisone
ANTIBIOTICS/therapeutic use; CORTISONE/therapeutic use; SULFONAMIDES/therapeutic use; WATERHOUSE-FRIDERICHSEN SYNDROME
Zur perakuten Meningokokkensepsis (Waterhouse-Friderichsen-Syndrom).